Found: 17
Select item for more details and to access through your institution.
Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 7, p. 3340, doi. 10.3390/ijms22073340
- By:
- Publication type:
- Article
How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.765747
- By:
- Publication type:
- Article
A gendered magnifying glass on COVID-19.
- Published in:
- Clinical & Molecular Allergy, 2020, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12948-020-00129-2
- By:
- Publication type:
- Article
Mechanisms of Drug Desensitization: Not Only Mast Cells.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.590991
- By:
- Publication type:
- Article
Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich's Syndrome.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study.
- Published in:
- Panminerva Medica, 2023, v. 65, n. 4, p. 473, doi. 10.23736/S0031-0808.21.04523-7
- By:
- Publication type:
- Article
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Effectiveness of low‐dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: A 2‐year real‐life experience.
- Published in:
- Clinical & Experimental Immunology, 2021, v. 205, n. 3, p. 346, doi. 10.1111/cei.13629
- By:
- Publication type:
- Article
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91851-7
- By:
- Publication type:
- Article
Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 13, doi. 10.3390/antib12010013
- By:
- Publication type:
- Article
EGPA Phenotyping: Not Only ANCA, but Also Eosinophils.
- Published in:
- Biomedicines, 2023, v. 11, n. 3, p. 776, doi. 10.3390/biomedicines11030776
- By:
- Publication type:
- Article
Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience.
- Published in:
- Biomedicines, 2022, v. 10, n. 11, p. 2688, doi. 10.3390/biomedicines10112688
- By:
- Publication type:
- Article
Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors.
- Published in:
- Biomedicines, 2021, v. 9, n. 10, p. 1497, doi. 10.3390/biomedicines9101497
- By:
- Publication type:
- Article
High proportion of inflammatory CD62L<sup>low</sup> eosinophils in blood and nasal polyps of severe asthma patients.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 1, p. 78, doi. 10.1111/cea.14153
- By:
- Publication type:
- Article
Blood CD62L<sup>low</sup> inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab.
- Published in:
- Allergy, 2023, v. 78, n. 12, p. 3154, doi. 10.1111/all.15909
- By:
- Publication type:
- Article
COVID‐19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.
- Published in:
- Allergy, 2021, v. 76, n. 3, p. 871, doi. 10.1111/all.14516
- By:
- Publication type:
- Article